The global Bleeding Disorders Market is entering a new phase of innovation as pharmaceutical companies, healthcare providers, and research organizations intensify efforts to improve the diagnosis and treatment of rare coagulation disorders. Advances in biotechnology, personalized medicine, and targeted therapies are creating unprecedented opportunities to enhance patient outcomes and address...